Join us for an
engaging webinar that delves into the role of intravital microscopy in advancing antibody-based therapies for
cancer treatment. Antibody therapeutics, including
antibody-drug conjugates (ADCs), represent a new generation of precision medicines targeting solid and hematologic tumors. However, understanding how these complex agents distribute and function within the body remains a critical challenge in drug development.
In this session, our expert speaker will showcase how
intravital microscopy enables
real-time visualization and quantification of antibody pharmacokinetics and mechanisms of action within living organisms. By directly observing therapeutic behavior at the cellular level, researchers can gain unprecedented insights into efficacy, biodistribution, and tumor microenvironment interactions.
Through real-world research examples, this webinar will highlight how dynamic in vivo imaging is driving innovation in antibody therapeutic development and helping to optimize treatment strategies for improved clinical outcomes.